Kyowa Kirin Co Ltd KYKOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $14.10
- Day Range
- $13.63–13.90
- 52-Week Range
- $4.20–18.00
- Bid/Ask
- $13.17 / $15.51
- Shares Outstanding
- 523.59M
- Market Cap
- $7.28B
- Volume/Avg
- 754 / 6,483
Key Statistics
- Price/Earnings (Normalized)
- 13.29
- Price/Sales
- 2.12
- Dividend Yield (Trailing)
- 3.02%
- Dividend Yield (Forward)
- 3.19%
- Dividend Payment Schedule
- Mar, Sep
- Total Yield
- 3.02%
Company Profile
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 3,503
- Website
- https://www.kyowakirin.com
Valuation
|
Metric
|
KYKOF
|
|---|---|
Price/Earnings (Normalized) | 13.29 |
Price/Book Value | 1.29 |
Price/Sales | 2.12 |
Price/Cash Flow | 9.47 |
Price/Earnings
KYKOF
Financial Strength
|
Metric
|
KYKOF
|
|---|---|
Quick Ratio | 2.30 |
Current Ratio | 2.84 |
Interest Coverage | 35.49 |
Quick Ratio
KYKOF
Profitability
|
Metric
|
KYKOF
|
|---|---|
Return on Assets (Normalized) | 8.07% |
Return on Equity (Normalized) | 10.01% |
Return on Invested Capital (Normalized) | 9.08% |
Return on Assets
KYKOF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|J>s#%#S | LOCK|TxPJ | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|#qG&S%K< | LOCK|#>Bq? | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|Z##zwV | LOCK|%b | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|HX?F$>G | LOCK|T%? | $31B | |||
| Viatris Inc
VTRS
| LOCK|b>qfs? | LOCK|$T@ | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|$w | LOCK|@r | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|S>&hX<k | LOCK|j@x | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|&VR%@G | LOCK|pwC | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|^YVL^% | LOCK|f$#? | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|Z<mgJ^ | LOCK|Gzm | $2B |
United States